Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

Comparing Copy Number Variations and SNPs

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...

Single Nucleotide Polymorphisms-SNPs

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Benchmark of Open-Access Star-Allele Callers to Accurately Assess Haplotypes and Phenotypes in Pharmacogenetic Studies.

Clinical pharmacology and therapeutics·2026

Same author

Unravelling the molecular mechanisms causal to type 2 diabetes across global populations and disease-relevant tissues.

Nature metabolism·2026

Same author

Integration of clinical and proteomic risk factors enhances prognostic modelling of incident vascular complications in type 2 diabetes.

Cardiovascular diabetology·2026

Same author

The effect of type 2 diabetes genetic predisposition on non-cardiovascular comorbidities.

Nature communications·2025

Same author

Correcting for Genomic Inflation Leads to Loss of Power in Large-Scale Genome-Wide Association Study Meta-Analysis.

Genetic epidemiology·2025

Same author

Unravelling the molecular mechanisms causal to type 2 diabetes across global populations and disease-relevant tissues.

medRxiv : the preprint server for health sciences·2025

Same journal

AI in variant analysis: fast track to genetic diagnoses.

Human genetics·2026

Same journal

Combined family-based association and linkage analyses in families affected by attention-deficit hyperactivity disorder.

Human genetics·2026

Same journal

Investigating the shared genetic architecture between selective immunoglobulin A deficiency and autoimmune diseases.

Human genetics·2026

Same journal

ARHI as a key regulator of EMT and metastasis in pancreatic cancer via the Notch-1 pathway.

Human genetics·2026

Same journal

Large-scale mitogenome analysis reveals complex maternal genetic connections between Sino-Tibetan- and Altaic-speaking populations.

Human genetics·2026

Same journal

Correction: A comprehensive and accessible model for co-segregation analysis in BRCA1, BRCA2, and PALB2 variant classification.

Human genetics·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Dec 19, 2025

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

Rare variant association testing in the non-coding genome.

Ozvan Bocher¹, Emmanuelle Génin^2,3

¹Génétique, Génomique Fonctionnelle Et Biotechnologies, Faculté de Médecine, Univ Brest, Inserm, Inserm UMR1078, Bâtiment E-IBRBS 2ieme étage, 22 avenue Camille Desmoulins, 29238, Brest Cedex 3, France. ozvan.bocher@univ-brest.fr.

|June 6, 2020

Summary

This summary is machine-generated.

Investigating rare genetic variants in non-coding DNA is crucial for understanding human diseases. This review explores methods to analyze these non-coding variants in association studies, overcoming current challenges.

More Related Videos

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

Rare Event Detection Using Error-corrected DNA and RNA Sequencing

Rare Event Detection Using Error-corrected DNA and RNA Sequencing

Published on: August 3, 2018

Related Experiment Videos

Last Updated: Dec 19, 2025

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

Rare Event Detection Using Error-corrected DNA and RNA Sequencing

Rare Event Detection Using Error-corrected DNA and RNA Sequencing

Published on: August 3, 2018

Area of Science:

Genetics
Genomics
Bioinformatics

Background:

Next-generation sequencing enables exploring genetic variants' role in diseases, especially rare variants.
Statistical methods for rare variant association testing typically focus on coding regions, defining genes as testing units.

Purpose of the Study:

To review experimental and statistical advancements for analyzing the non-coding genome.
To discuss strategies for incorporating rare non-coding variants into association tests for disease susceptibility.

Main Methods:

Discussing challenges in defining non-coding testing units and selecting functional variants.
Highlighting recent developments in understanding non-coding genome organization and variant impact on gene expression.
Reviewing existing studies that have incorporated non-coding variants into association tests.

Main Results:

The non-coding genome, representing the majority of DNA, is understudied despite its potential role in disease.
Significant challenges exist in defining non-coding regions as testing units and predicting variant function.
Few studies have successfully integrated non-coding variants into association analyses, requiring novel approaches.

Conclusions:

Overcoming challenges in non-coding genome analysis is essential for comprehensive disease association studies.
Future research should focus on experimental and statistical methods to better understand non-coding variant impact.
Integrating non-coding rare variants into association tests holds promise for uncovering new disease mechanisms.